These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8335892)

  • 1. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.
    Layton GT; Harris SJ; Gearing AJ; Hill-Perkins M; Cole JS; Griffiths JC; Burns NR; Kingsman AJ; Adams SE
    J Immunol; 1993 Jul; 151(2):1097-107. PubMed ID: 8335892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.
    Layton GT; Harris SJ; Myhan J; West D; Gotch F; Hill-Perkins M; Cole JS; Meyers N; Woodrow S; French TJ; Adams SE; Kingsman AJ
    Immunology; 1996 Feb; 87(2):171-8. PubMed ID: 8698376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
    Harris SJ; Gearing AJ; Layton GT; Adams SE; Kingsman AJ
    Immunology; 1992 Nov; 77(3):315-21. PubMed ID: 1362183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.
    Nehete PN; Casement KS; Arlinghaus RB; Sastry KJ
    Cell Immunol; 1995 Feb; 160(2):217-23. PubMed ID: 7720083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice.
    Harris SJ; Woodrow SA; Gearing AJ; Adams SE; Kingsman AJ; Layton GT
    Vaccine; 1996 Jul; 14(10):971-6. PubMed ID: 8873390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
    Schirmbeck R; Deml L; Melber K; Wolf H; Wagner R; Reimann J
    Vaccine; 1995 Jun; 13(9):857-65. PubMed ID: 7483809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R; Böltz T; Deml L; Modrow S; Wolf H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.
    Peifang S; Pira GL; Fenoglio D; Harris S; Costa MG; Venturino V; Dessì V; Layton G; Laman J; Huisman JG
    Clin Exp Immunol; 1994 Sep; 97(3):361-6. PubMed ID: 7915974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN; Arlinghaus RB; Sastry KJ
    Viral Immunol; 1994; 7(4):189-97. PubMed ID: 7576033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH; Tuskan RG; Lewis GK
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120.
    Sastry KJ; Nehete PN; Venkatnarayanan S; Morkowski J; Platsoucas CD; Arlinghaus RB
    Virology; 1992 Jun; 188(2):502-9. PubMed ID: 1316670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
    Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ
    Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
    Wagner R; Deml L; Schirmbeck R; Niedrig M; Reimann J; Wolf H
    Virology; 1996 Jun; 220(1):128-40. PubMed ID: 8659105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes.
    Chang JS; Choi MJ; Kim TY; Cho SY; Cheong HS
    Vaccine; 1999 Mar; 17(11-12):1540-8. PubMed ID: 10195791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast retrotransposon particles as antigen delivery systems.
    Kingsman AJ; Burns NR; Layton GT; Adams SE
    Ann N Y Acad Sci; 1995 May; 754():202-13. PubMed ID: 7625653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.